Evidence map›Paper›PMID 35434022›Full record

ReviewAnnals of translational medicine2022

Role of lipid rafts in persistent

Renjie Liu, Yuzuo Chen, Lu Yang, Mingjiang Bie, Baoning Wang

Open access · diamondAbstract readReview
In one paragraph

Review in Annals of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Ergosterol from Yeasts PromotesInternational journal of molecular sciences · 2026
    Article
  2. Trained Immunity and Trained Tolerance: The Case ofInternational journal of molecular sciences · 2024
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Renjie LiuDepartment of Microbiology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, China.
Yuzuo ChenDepartment of Microbiology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, China.
Lu YangDepartment of Microbiology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, China.
Mingjiang BieDepartment of Laboratory Medicine, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Baoning WangDepartment of Microbiology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, China.
West China Medical Center of Sichuan University · CNSichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objective: The distribution of components in the cell membrane is not uniform, but is organized into specific functional microdomains, known as "lipid rafts". These lipid rafts consist of cholesterol, sphingolipids, and various proteins. Studies have shown that lipid rafts contain multiple proteins that are closely related to signal transduction and immune response. Furthermore, lipid rafts are the sites where a variety of pathogens invade the cells, and are associated with the persistent infection of some pathogens, especially Methods: Papers on lipid rafts were retrieved to analyze the evolution of the definition of lipid raft, research techniques, and studies on the correlation of lipid rafts with pathogens infecting host cells. Key Content and Findings: Hp uses cholesterol-α-glucosyltransferase (CGT) to extract cholesterol from the lipid rafts of host cell membrane and destroys the integrity of the lipid rafts, which contributes to its immune escape; Using drugs to inhibit the destruction of lipid rafts by CGT can inhibit the growth of Hp and help the body clear Hp. Conclusions: Lipid rafts are key to persistent Hp infection, and a new field of research on pathogen-host cell interactions and signal transduction. Researches on lipid rafts may promote a new breakthrough in the field of treatment of Hp.

Indexed as

cholesterolHelicobacter pylori (Hp)immunityLipid raftpersistent infection

Identifiers

PMID35434022
PMCPMC9011227
OpenAlexW4224293253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.